ArticleOncoimmunology2025

Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumab.

Hifaa Al Remawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.